A medical team at the Amsterdam University Medical Centre (AUMC) in the Netherlands completed the first-in-human ventricular ...

NeuroOne (Nasdaq:NMTC) announced today that it filed an FDA 510(k) submission for its trigeminal nerve ablation technology.

Artedrone says preclinical studies show its Sasha microbotic system can autonomously perform mechanical thrombectomy for ...

Epiminder announced that it received FDA de novo authorization for its implantable continuous electroencephalogram monitoring ...

CereVasc announced today that it received FDA breakthrough device designation for its investigational eShunt system.

Boston Scientific (NYSE: BSX) shares ticked up before hours today on first-quarter results that topped the consensus forecast ...

Surgical stock fell despite beating expectations as the company warned Trump's import taxes could have a significant impact.

R3 Vascular announced that a doctor treated the first patient in the ELITE-BTK pivotal trial of its drug-eluting ...

Orchestra BioMed (Nasdaq:OBIO) received FDA breakthrough device designation for its atrioventricular interval modulation ...

BD (NYSE: BDX) announced today that it received FDA 510(k) clearance for its Phasix ST umbilical hernia patch.

The regulatory approval in the EU comes approximately six months after Novocure secured FDA approval of the system.

Perfuze announced today that it completed enrollment in its U.S. FDA investigational exemption (IDE) trial evaluating its ...